Conference

Nanyang Biologics Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum

22 March 2026 · Nanyang Biologics

NYB attended NVIDIA GTC 2026 with the goal of sharing our nature-inspired AI drug discovery platform and gathering technical feedback from the broader research community.

Across the week we engaged with computational chemists, infrastructure leads, and longevity-focused investors, demonstrating how DTIGN and LigoSpace combine graph neural networks with botanical chemistry to surface novel therapeutic candidates.

We came away with valuable scientific exchange, external feedback on our methodology, and cross-sector dialogue that will shape the next quarter of platform work.

All news Press enquiry

Conference
Nanyang Biologics to Exhibit at NVIDIA GTC 2026
Nanyang Biologics is pleased to announce that we will be exhibiting at NVIDIA GTC 2026, taking place from March 16–19, 2026.
Publication
Introducing LigoSpace: Advancing Bioactivity Prediction at NeurIPS 2025
Nanyang Biologics is excited to share that its latest research, LigoSpace, developed in collaboration with Nanyang Technological University Singapore (NTU), has been presented at NeurIPS 2025, one of the world's most prestigious conferences in AI and ML.

Research Briefs

Monthly digest of our AI drug discovery progress, publications, and longevity science.

Nanyang Biologics Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum

Related

Nanyang Biologics to Exhibit at NVIDIA GTC 2026

Introducing LigoSpace: Advancing Bioactivity Prediction at NeurIPS 2025

Subscribe to NYB Research Briefs